Introduction {#S1}
============

Enterococci are Gram-positive, facultative anaerobic bacteria that are members of the normal flora in the human gastrointestinal tract but have been recognized as important pathogens worldwide \[[@R01], [@R02]\]. *Enterococcus faecalis* and *Enterococcus faecium* are the most prevalent species isolated from the urinary tract and wound infections, which affect mainly patients admitted to the medical care centers \[[@R03]-[@R06]\]. The disruption of the normal skin barrier, the immunocompromised state, prolonged hospitalization and antibiotic therapy put burns patients at a high risk of acquiring nosocomial infections including enterococcal infections \[[@R07]\].

Enterococcal infections can be difficult to treat because they have a remarkable ability of adaptation when are exposed to antibiotics; they have intrinsic resistance to several antimicrobial agents and have a tremendous capacity to acquire high levels of resistance to antibiotics \[[@R08], [@R09]\]. Vancomycin-resistant enterococci (VRE) and high-level gentamicin-resistant (HLGR) isolates have emerged as important pathogen in Iran as well as in other countries, which create serious challenges for treating the infected patients \[[@R09]-[@R11]\].

There are several reports on the endemicity of VRE and HLRG in Iran but there is a lack of information on enterococcal stains isolated form burn centers \[[@R03], [@R12]\]. This study was designed to determine the molecular characteristics and antimicrobial resistance of *enterococcal* strains isolated from patients in a burn center in Iran.

Materials and methods {#S2}
=====================

BACTERIAL ISOLATES {#S2a}
------------------

Twenty-seven enterococcal isolates were collected from wound specimens of patients with burn injury, during April to September 2012, in a burn hospital in Tehran. Only one isolate per patient was included in the study. Identification of enterococci was performed based on a series of conventional microbiological tests including Gram reaction, catalase reaction, presence of pyrrolidonyl arylamidase (PYR), growth on bile-aesculin agar and 6.5% NaCl media, motility test, arginine decarboxylation in Moeller decarboxylase media, pyruvate utilization, and fermentation of arabinose, raffinose, mannitol and ribose \[[@R03]\]. To confirm the identity of the isolates as *E. faecalis* or *E. faecium* the ddlE gene was amplified by a polymerase chain reaction (PCR) method as described by Dutka-Malen et al. \[[@R13]\].

ANTIMICROBIAL SUSCEPTIBILITY TESTING {#S2b}
------------------------------------

Antibiotic susceptibility of the strains was performed by the disk diffusion method. The antibiotics (Mast Group Ltd., Merseyside, UK) tested were ciprofloxacin (5 μg), erythromycin (15 μg), tetracycline (30 μg), and quinupristin- dalfopristin (15 μg). High-level resistance to gentamicin was also determined by disk diffusion method on Mueller-- Hinton agar (Conda S.A., Madrid, Spain) using 120 μg gentamicin disk. The minimal inhibitory concentration (MIC) of vancomycin was determined by the standard agar dilution test on *Brain Heart Infusion* agar (Conda S.A., Madrid, Spain). All Antibiotic susceptibilities were performed and interpreted according to the criteria of the Clinical and Laboratory Standards Institute (CLSI) guidelines \[[@R14]\].

DNA EXTRACTION AND GENE DETECTION {#S2c}
---------------------------------

DNA extraction was performed as described previously and this DNA was used as a template for PCR analysis \[[@R11]\]. All strains were screened for genes encoding resistance to aminoglycoside \[*aac(6\')-Ie-aph(2\'\')-Ia, aph (3\'), ant (4\')*\], vancomycin (*vanA, vanB*), tetracycline (*tetK, tetL, tetM, tetO*), and resistance to erythromycin (*ermA, ermB, ermC*) by PCR and multiplex PCR-based methods, using specific primers \[[@R03], [@R11],[@R12], [@R15], [@R16]\].

RANDOM AMPLIFIED POLYMORPHIC DNA (RAPD)-PCR {#S2d}
-------------------------------------------

The RAPD-PCR assay was carried out in 25 μl reaction volumes containing 0.5 μM of each primer (5′-AGCGGGCCAA-3′ and 5′- ACGGCCGACC-3′), 12.5 μl of PCR master (Sinaclone Inc, Iran) and 5 μl of DNA template. Cycling conditions were as follow: initial denaturation at 95°C for 5 min, followed by 30 cycles of 95°C for 1 min, 38.5°C for 1 min, and 72°C for 2 min, and final extension at 72°C for 10 min. PCR products were then separated by electrophoresis in 1.4% agarose gel with 0.5X TBE buffer. DNA bands were observed by staining with KBC power load dye (Kawsar Biotech Co. Iran) and photographed under UV illumination. RAPD patterns were analyzed by visual inspection. Only the obvious, prominent and reproducible bands from repeated experiments (at least twice) were considered and any pattern differing by one or more bands was classified as a distinct RAPD type.

Results {#S3}
=======

Distribution of species according to conventional microbiological tests and PCR method included 19 (70.3%) *E. faecalis* and 8 (29.7%) *E. faecium*. The prevalence of antimicrobial resistance pattern and RAPD types have been summarized in [Table I](#T1){ref-type="table"}. In the present study, no VRE was recovered and all enterococcal isolates showed complete sensitivity to vancomycin with MIC ≤ 0.5 μg/ml.

###### 

The distribution of antimicrobial resistance genes, virulence genes and biofilm production among enterococcal species.

  Isolate   Date of Isolation   Species       Resistance pattern                                     Resistance genes                                         RAPD type
  --------- ------------------- ------------- ------------------------------------------------------ -------------------------------------------------------- -----------
  1         20/4/2012           E. faecalis   E[^\*^](#T1FN1){ref-type="table-fn"},GM, TET,SYN,CIP   tetM,ermA, aac(6\')-Ie-aph(2\'\')-Ia, ant(4\')           A
  2         22/4/2012           E. faecium    GM, TET, SYN                                           tetM, aac(6\')-Ie-aph(2\'\')-Ia, ant(4\')                B
  3         24/4/2012           E. faecium    E,GM, TET,SYN,CIP                                      tetM, aac(6\')-Ie-aph(2\'\')-Ia                          H
  4         26/4/2012           E. faecium    E,GM, TET                                              tetL, tetM, ermB, aac(6\')-Ie-aph(2\'\')-Ia, ant(4\')    G
  5         26/4/2012           E. faecalis   E,GM, TET                                              tetM,ermB, aac(6\')-Ie-aph(2\'\')-Ia                     P
  6         1/5/2012            E. faecalis   E,GM, TET,SYN,CIP                                      tetM, ermB, aac(6\')-Ie-aph(2\'\')-Ia                    A
  7         4/5/2012            E. faecium    E,GM, TET                                              tetL, tetM, ermB, aac(6\')-Ie-aph(2\'\')- Ia, ant(4\')   J
  8         8/5/2012            E. faecalis   E,GM, TET,SYN,CIP                                      ermB, aac(6\')-Ie-aph(2\'\')-Ia                          A
  9         15/5/2012           E. faecalis   E,GM, TET,SYN,CIP                                      tetM, aac(6\')-Ie-aph(2\'\')-Ia                          N
  10        2/6/2012            E. faecalis   E,GM, TET,SYN,CIP                                      tetM,ermB, aac(6\')-Ie-aph(2\'\')-Ia                     A
  11        12/7/2012           E. faecalis   E,GM, TET,SYN,CIP                                      tetM,ermA, aac(6\')-Ie-aph(2\'\')-Ia, ant(4\')           A
  12        14/7/2012           E. faecalis   E,GM, TET,SYN,CIP                                      tetM,ermA, aac(6\')-Ie-aph(2\'\')-Ia, ant(4\')           A
  13        14/7/2012           E. faecalis   E,GM, TET,SYN,CIP                                      tetM, ermA, aac(6\')-Ie-aph(2\'\')-Ia, ant(4\')          A
  14        21/7/2012           E. faecalis   E,GM, TET,SYN,CIP                                      tetM, ermA, aac(6\')-Ie-aph(2\'\')-Ia, ant(4\')          A
  15        23/7/2012           E. faecium    TET                                                    tetM                                                     M
  16        25/7/2012           E. faecium    E, GM,TET,SYN,CIP                                      tetM,ermB, aac(6\')-Ie-aph(2\'\')-Ia                     F
  17        7/8/2012            E. faecalis   E, GM,TET,SYN,CIP                                      tetM, ermA, aac(6\')-Ie-aph(2\'\')-Ia, ant(4\')          A
  18        7/8/2012            E. faecalis   GM,SYN,CIP                                             tetM,ermB, aac(6\')-Ie-aph(2\'\')-Ia                     E
  19        14/8/2012           E. faecalis   E, GM,TET,SYN,CIP                                      ermA, aac(6\')-Ie-aph(2\'\')-Ia, ant(4\')                D
  20        14/8/2012           E. faecalis   E, GM,TET,SYN,CIP                                      tetM,ermB, aac(6\')-Ie-aph(2\'\')-Ia, ant(4\')           I
  21        21/8/2012           E. faecalis   E, GM,TET,SYN,CIP                                      tetM,ermA, aac(6\')-Ie-aph(2\'\')-Ia, ant(4\')           A
  22        25/8/2012           E. faecalis   E, GM,TET,SYN,CIP                                      tetM,ermA aac(6\')-Ie-aph(2\'\')-Ia, ant(4\')            A
  23        11/9/2012           E. faecalis   E, GM,TET,SYN,CIP                                      tetM,tetO, ermB, aac(6\')-Ie-aph(2\'\')-Ia, ant(4\')     K
  24        11/9/2012           E. faecium    E, GM                                                  aac(6\')-Ie-aph(2\'\')-Ia, ant(4\')                      Q
  25        16/9/2012           E. faecalis   E, GM,TET,SYN,CIP                                      tetM, ermB, aac(6\')-Ie-aph(2\'\')-Ia                    C
  26        16/9/2012           E. faecalis   E, GM,TET,SYN,CIP                                      tetM aac(6\')-Ie-aph(2\'\')-Ia, ant(4\')                 L
  27        16/9/2012           E. faecium    E, GM,TET,SYN,CIP                                      tetM,tetO, ermB, aac(6\')-Ie-aph(2\'\')-Ia, ant(4\')     O

E, Erythromycin; G, Gentamicin; SYN, Quinupristin-dalfopristin; TET, Tetracycline; CIP, Ciprofloxacin

All isolates at least exhibited resistance to one antibiotic and 6 different profiles were observed on the basis of their antibiotic resistance patterns. High-level resistance to gentamicin and multiple drug resistance were observed in 96.2% of isolates. The most frequent profile was resistance to erythromycin, gentamicin, tetracycline, quinupristin-dalfopristin and ciprofloxacin that was observed in 74% of isolates.

The most prevalent aminoglycoside resistance gene was *aac(6\')-Ie-aph(2\'\')-Ia*, found in 96.2% (26/27) of the isolates. These genes were detected in all HLGR isolates. The *ant (4\')* gene was detected in 62.9% (17/27) of isolates. The most prevalent tetracycline resistance gene was *tetM*, found in 85.1% (23/27) of the isolates followed by *tetL* and *tetO* found in 7.4% (2/27) of the isolates. The *ermA* and *ermB* genes were detected in 33.3% (9/27) and 44.4% (12/27) of the isolates respectively. The *aph (3\'), tetK, ermC, vanA,* and *vanB* genes were not detected in any of the enterococcal isolates in this study.

To determine the degree of clonality among enterococcal isolates, the RAPD typing was used. RAPD analysis yielded 17 distinct profiles among 27 investigated isolates ([Fig. 1](#F1){ref-type="fig"}). One clusters of isolates shared the same RAPD patterns, while 16 isolates had unique RAPD patterns. A dominant RAPD type designated as A, that consisted 11 isolates of *E. faecalis* and were HLGR.

![RAPD-PCR profiles of *Enterococcus faecalis* and *E. faecium* isolates. Lanes 1and 2; DNA size marker (100bp), Lanes A-Q; Enterococcal isolates with different RAPD patterns.](2421-4248-57-E197-g001){#F1}

Discussion {#S4}
==========

Among Enterococci isolates, *E. faecalis* and *E. faecium* are the most common species caused enterococcal nosocomial infections \[[@R01]\]. In our study, the most prevalent species was *E. faecalis* (70.3%) followed by *E. faecium* (29.7%) isolated from burn wound infections. Similar results were reported for clinical isolates by other studies \[[@R03], [@R11], [@R16], [@R17]\].

In the treatment of enterococcal infections, the combination of gentamicin with a beta lactam antibiotic or a glycopeptide is used to obtain a synergistic bactericidal effect. However, strains that are highly resistant to gentamicin are no longer susceptible to the combination therapy \[[@R18]\]. Several studies have demonstrated that VRE have caused both outbreaks and endemic infections in burn units \[[@R05], [@R06]\], However, in this study, there were no VRE isolates and more than 96% of isolates were HLGR and 74% of them were simultaneously resistant to erythromycin, tetracycline, quinupristin-dalfopristin and ciprofloxacin. Our study is the first investigation on enterococcal resistance among burn patients in Iran and the findings indicated that vancomycin keeps its therapeutic effects against enterococcal infections.

Resistance against aminoglycosides among enterococci is commonly due to enzymatic modification. Genes encoding aminoglycoside-modifying enzymes (AMEs) are often carried on transposable elements. One of the most prevalent AMEs genes among enterococci is *aac(6\')-Ie-aph(2\'\')-Ia* encoding a bifunctional enzyme *Aac(6\')-Ie-Aph(2\'\')-Ia* which confers resistance to virtually all of the clinically available aminoglycosides including gentamicin \[[@R11], [@R19]\].

In the current study, as in many other reports, the *aac(6\')- Ie-aph(2\'\')-Ia* gene was the most prevalent AME gene, encountered in 96.2% of isolates followed by the *ant (4\')* gene and was detected in 62.9% of isolates \[[@R16], [@R20]\].

Acquired resistance to tetracyclines and macrolides in enterococci is often by mobile genetic elements \[[@R20]\]. In the present study, as in many previous reports, the most common tetracycline and erythromycin resistance mechanism was mediated by the *tetM* and *ermB* genes, respectively \[[@R21]-[@R25]\]. To take preventive measures and apply infection control, identification of the source of infection and nature of outbreaks are required. RAPD-PCR has become a reliable tool for the differentiation and identification of enterococci from clinical origin \[[@R26]-[@R28]\]. In this study, RAPD-PCR profiles showed that eleven *E. faecalis* isolates shared identical banding patterns. In addition, the results of RAPD typing corresponded with antibiogram findings and the resistance genes patterns for eight of these eleven isolates. This could be explained by the predominance or an outbreak of a particular clonal group of *E. faecalis* with high-level gentamicin resistance in the assessed burn unit.

In conclusion, we found that over the examination time period one RAPD genotype was the common type and was disseminated among patients in the burn unit. Interestingly, most of these strains had an identical or very similar antibiotic and gene resistance pattern.
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